On Wednesday, JB Chemicals and Pharmaceuticals stock closed 6.09 per cent higher at Rs 2,813.90 per scrip compared to its previous close of Rs 2,652.45, the stock jumped on account of a USFDA approval
Read More
India's Aster DM Healthcare reported a nearly 93 per cent fall in its first-quarter profit on Monday, its fourth straight quarterly profit fall, dragged by losses from its new hospitals and a one-time tax expense. The company's consolidated net profit fell to Rs 4.9 crore (nearly USD 590,000) for the quarter ended June 30, compared with Rs 68.5 crore a year earlier
Read More
Medanta's total income in Q1FY24 stood at Rs. 794 crore; growth of 26.8 per cent y-o-y against Rs 626 crores in the same quarter last year
Read More
Bangalore-based pharmaceutical company Biocon on Thursday announced its consolidated financial results for the first quarter that ended 30 June 2023, the company registered a 58 per cent rise in its consolidated revenues from operations year on year
Read More
JB Chemicals & Pharmaceuticals announced its financial results for the quarter ended 30th June 2023 on Wednesday. For the first quarter of FY24 ended 30th June 2023, JB Pharma recorded revenue of Rs 896 crores growing 14 YoY from Rs 785 crores in the corresponding quarter
Read More
Max Healthcare recorded an increase in ARPOB (Average Revenue Per Occupied Bed) of over 13 per cent YoY. Profit after tax (PAT) for the quarter stood at Rs 291 crore compared to Rs 229 crore in Q1 FY23 up by 27 per cent YoY
Read More
Torrent Pharma reported its quarter-one earnings on Monday, the pharma major has recorded sales worth Rs 2,591 crores for the quarter that ended in June 2023, a 10 per cent rise over the same quarter in the previous year
Read More
Alembic's Profit After Tax (PAT) was recorded at Rs 121 crores in Q1FY24 against a net loss of Rs 86 crores in the same quarter last year whereas the profits dipped by 21 per cent quarter on quarter (QoQ) compared with Rs 153 crores recorded in the March quarter
Read More
